v2.4.0.6

Restructuring Activities | 12 Months Ended
--- | ---
Dec. 31, 2011
Restructuring and Related Activities [Abstract] |
Restructuring Activities | Restructuring Activities In April 2010, Caire Inc., a wholly-owned subsidiary of the Company, announced its plan to close its liquid oxygen therapy manufacturing facility in Plainfield, Indiana and relocate the manufacturing and customer service operations to a facility close to existing BioMedical operations in Canton, Georgia. The Plainfield facility was acquired as part of the 2009 acquisition of the liquid oxygen therapy business of Covidien plc. The closure was substantially completed in the second quarter of 2011. The total cost of the restructuring was approximately $7,300 which includes asset impairment charges. The cost includes cash expenditures for employee retention and separation benefits, as well as lease exit costs and loss on disposal of remaining assets. The Company recorded $3,497 and $3,730 for the years ended December 31, 2011 and 2010, respectively, related to the closure of the Plainfield, Indiana BioMedical facility. The Company also recorded $1,172 in restructuring costs for employee separation benefits related to the integration of SeQual Technologies Inc., which was acquired on December 28, 2010. These charges were recorded in cost of sales ($2,061 and $2,579 for the years ended December 31, 2011 and 2010, respectively), selling, general and administrative expenses ($2,414 and $531 for the years ended December 31, 2011 and 2010, respectively), loss on disposal of assets ($1,218 for the year ended December 31, 2011) and asset impairment charges ($1,646 for the year ended December 31, 2010). During 2009, the Company recorded $8,020, related to termination benefits primarily in the Distribution & Storage and BioMedical segments and the write-down to net realizable value of certain assets at the Denver, Colorado facility and land held for sale in Plaistow, New Hampshire. These charges were recorded in cost of sales ($3,605), selling, general and administrative expenses ($3,185) and asset impairment charges ($1,230). The following tables summarize the Company’s restructuring activities for the years ended December 31, 2011, 2010 and 2009:
| Year Ended December 31, 2011
| Energy & Chemicals |  | Distribution & Storage |  | BioMedical |  | Corporate |  | Total
Balance as of January 1, 2011 | $ | 103 |  |  | $ | 387 |  |  | $ | 2,088 |  |  | $ | — |  |  | $ | 2,578 |
Restructuring charges | — |  |  | 315 |  |  | 4,940 |  |  | 437 |  |  | 5,692 |
Asset impairment | — |  |  | — |  |  | (1,218 | ) |  | — |  |  | (1,218 | )
Cash payments | (103 | ) |  | (587 | ) |  | (4,812 | ) |  | (437 | ) |  | (5,939 | )
Balance as of December 31, 2011 | $ | — |  |  | $ | 115 |  |  | $ | 998 |  |  | $ | — |  |  | $ | 1,113 |
| Year Ended December 31, 2010
| Energy & Chemicals |  | Distribution & Storage |  | BioMedical |  | Corporate |  | Total
Balance as of January 1, 2010 | $ | 682 |  |  | $ | 1,608 |  |  | $ | 503 |  |  | $ | 88 |  |  | $ | 2,881 |
Restructuring charges | — |  |  | (45 | ) |  | 4,723 |  |  | 78 |  |  | 4,756 |
Asset impairment | — |  |  | — |  |  | (1,546 | ) |  | (100 | ) |  | (1,646 | )
Cash payments | (579 | ) |  | (1,176 | ) |  | (1,592 | ) |  | (66 | ) |  | (3,413 | )
Balance as of December 31, 2010 | $ | 103 |  |  | $ | 387 |  |  | $ | 2,088 |  |  | $ | — |  |  | $ | 2,578 |
| Year Ended December 31, 2009
| Energy & Chemicals |  | Distribution & Storage |  | BioMedical |  | Corporate |  | Total
Balance as of January 1, 2009 | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Restructuring charges | 1,004 |  |  | 3,397 |  |  | 3,336 |  |  | 283 |  |  | 8,020 |
Asset impairment | — |  |  | (234 | ) |  | (996 | ) |  | — |  |  | (1,230 | )
Cash payments | (322 | ) |  | (1,555 | ) |  | (1,837 | ) |  | (195 | ) |  | (3,909 | )
Balance as of December 31, 2009 | $ | 682 |  |  | $ | 1,608 |  |  | $ | 503 |  |  | $ | 88 |  |  | $ | 2,881 |

X
- Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140864-122747 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration